The role of microparticles in VTE
Cancer-associated venous thromboembolism (VTE) causes significant morbidity and mortality in patients and constitutes...
Most Read
An interview with Raffaella Giavazzi
Raffaella Giavazzi during her 5th Simon Karpatkin Memorial Lecture at the 9th ICTHIC in...
WEBINAR: Challenges in the management of fragile CAT patients (older patient population & palliative care)
A new webinar is coming; register here 15 May 2023 – 18:00-19:00 CET Chair: Annie Young Spakers: Jay Easaw,...
Arterial thromboembolism can also be the first clinical manifestation of a neoplasm
Several studies showed that venous thrombosis can be the first clinical manifestation of an occult neoplasm. For this...
Trial updates In thromboprophylaxis of cancer-related venous thromboembolism
The past decade has seen a large number of studies focusing on identifying cancer patients at high risk for venous...
Isolated Distal DVT In Cancer Patients: What Do Recent Studies Suggest?
In a recent issue of the Journal of Thrombosis and Hemostasis, we report that cancer patients with isolated distal deep...
Lessons from the CATCH study: beware of the risk of bleeding in neoplastic patients treated for VTE
The results of an interesting secondary analysis of the CATCH study were published recently and they are useful for a...
Coagulopathy and thrombosis in COVID-19 patients: parameters to be checked to assess disease severity
As the clinical evidence keeps on accumulating, we can clearly state that coronavirus disease 2019 (COVID-19) very...
Developmental hemostasis and its relevance to pediatric thrombosis
The coagulation system of neonates and children evolves with age, as evidenced by marked physiological differences in...
ISTH 2018 – BETHANY SAMUELSON BANNOW
We met with Dr. Bethany Samuelson Bannow during the 64th Annual Scientific and Standardization Committee (SSC) meeting...